XERS
Xeris BiopharmaANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
XERS vs peer average
80/100
XERS vs. peer average (A vs. C)
Grade spread
A 1 · B 3 · C 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
ABSI is the first available peer comparator.
Same-sector and similar-market-cap candidate, but no operating-comparability evidence supports using it as a valuation anchor.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
XERS
Xeris Biopharma
ABSI
Absci
Grade
A
F
Momentum
64
90
Value
61
41
Sentiment
100
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs ABSI
XERS / ABSI
Grade Position
Above peers
XERS vs. peer average (A vs. C)
80/100
Momentum
64
ABSIValue
61
XERSSentiment
100
XERSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs XERS
ABSI is the first peer returned for this comparison set.

